Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NewHope: Vivitrol for Opioid Dependent HIV+ Released Prisoners
NCT01246401Phase 2Completed
- Sponsor
- Yale University
- Start
- Mar 2011
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in opioid use disorder (OUD), sponsored by Yale University. Started Mar 2011; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01246401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01246401.